SEC Form 4 · accession 0001193125-26-279753
Pharvaris N.V. · PHVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peng Lu
Officer — Chief Medical Officer
Period of report
Jun 18, 2026
Accepted (ET)
Jun 23, 2026 · 5:07 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001830487
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 18, 2026 | M | 300 | $2.59 | A | 65,931 | D | |
| Common Stock | Jun 18, 2026 | S | 300 | $34.00 | D | 65,631 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $2.59 | Jun 18, 2026 | M | 300 | D | — | Feb 3, 2030 | Common Stock | 245,308 | 205,008 | D |
Explanation of responses
- F1This is a scheduled exercise and sale from 10b5-1 trading plan.
- F225% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.